Fig. 4From: Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinomaCorrelation of the serum FGF19 levels with AFP and DCP. Spearman’s rank correlation coefficient analyses showed no correlation of serum FGF19 levels with AFP (a) or DCP (b)Back to article page